Emad N. Estemalik MD, MBA

Emad Estemalik MD, MBA is the Chair for International Business Development at Cleveland Clinic’s International Operations, Section Head for Headache and Facial Pain at Cleveland Clinic’s Neurological Institute, and Assistant Professor of Neurology at the Lerner School of Medicine of Case Western Reserve University.

He joined Cleveland Clinic as a staff member in 2013. He is board-certified by the American Board of Psychiatry and Neurology and Headache Medicine by the United Council for Neurological Subspecialties. He is a member of the American Headache Society.

Dr. Estemalik completed his residency at Cleveland Clinic in 2012. He also completed a one-year fellowship in headache medicine following his residency. He received his MD from the Ain Shams Medical School in Cairo, Egypt in 2005. He also holds an MBA from the Weatherhead School of Management at Case Western Reserve University.

Dr. Estemalik leads the efforts of expanding Cleveland Clinic’s global outreach to enhance the enterprise’s international presence, direct its international resources toward building quality relationships with global healthcare institutions, and identify strategic market opportunities to direct investment strategies.

Dr. Estemalik also serves on the leadership committee of Cleveland Clinic’s Neurological Institute (NI). His role includes executing Cleveland Clinic’s vision and helping achieve a high-performing institute while integrating education, research, and medical innovation. His focus is to enhance the capabilities of medical informatics while directing NI’s programmatic domestic and international growth and further enhancing the development of service lines that better serve patients. He also sits on NI’s marketing and philanthropy committee.

Dr. Estemalik speaks Arabic, German, French, and Spanish. Born in Cairo, Egypt, he lived in various countries of the Middle East in addition to several years in Hamburg, Germany.

Dr. Estemalik’s areas of interest are migraine headaches, trigeminal autonomic cephalgias, and facial neuralgias. He is a national and international speaker on various topics of headache disorders and their comorbidities. He is an active participant in various headache clinic trials at Cleveland Clinic. He is an active reviewer for the Cleveland Clinic Journal of Medicine, Pain Practice Journal, and the Egyptian Journal of Neurology and Neurosurgery. He consults and serves on faculty advisory boards of Lundbeck, Lilly, AbbVie, and Teva Pharmaceuticals.